CELLULAR MECHANISMS OF DRUG TRANSPORT IN CHOROID PLEXUS
脉络丛药物转运的细胞机制
基本信息
- 批准号:2181281
- 负责人:
- 金额:$ 17.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-01-01 至 1998-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Nucleosides, nucleobases and their analogs (e.g., ganciclovir, acyclovir,
dideoxyinosine, azidothymidine) have rapidly become important therapeutic
agents in the treatment of a number of central nervous system viral
infections including herpes-simplex encephalitis, cytomegalovirus
retinitis and AIDS-related dementia complex. To exert a biological effect
in the central nervous system, these compounds must penetrate either the
blood brain barrier (BBB) or the blood-cerebrospinal fluid barrier (i.e.,
choroid plexus), the two barriers that provide a protected environment for
the brain. Although the BBB has received considerable attention in the
literature, it is becoming increasingly apparent that the choroid plexus
plays an essential role in mediating the transport of many important
compounds into the central nervous system. Notably, during the past
granting period, we demonstrated the presence of a novel, broadly-
selective Na+-nucleoside cotransporter (N3) in the choroid plexus. In
addition, we recently obtained exciting preliminary data suggesting that
there is a novel Na+-dependent transporter for nucleobases in the choroid
plexus. The overall goal of studies in this competitive renewal
application is to understand the mechanisms by which nucleosides,
nucleobases and their structural analogs are transported in the choroid
plexus. In the proposed studies, we plan to: (1) determine the structure
of N3 in rabbit choroid plexus using an expression cloning strategy; (2)
determine the tissue distribution in the rabbit of the mRNA transcript
encoding N3; (3) determine the location (i.e., basolateral or brush border
membrane) of N3 in the choroid plexus; (4) determine the mechanisms by
which purine and pyrimidine nucleosides are transported in human choroid
plexus; and (5) determine the mechanisms by which nucleobases are
transported in the choroid plexus. Methods for determining the structure
of N3 will involve expression cloning in Xenopus laevis oocytes,
determining the primary sequence of the cDNA encoding N3 and deducing its
amino acid sequence. To identify the location of N3 as well as of
equilibrative nucleoside transporters in the choroid plexus, kinetic
studies using isotopic uptake procedures will be carried out in cultured
choroid plexus monolayers grown on porous filters and in isolated membrane
vesicles. Isotopic uptake studies in ATP-depleted tissue slices will be
used in characterizing nucleoside transport in human choroid plexus and
nucleobase transport in rabbit choroid plexus. In particular, we will
elucidate the interactions of clinically relevant nucleoside analogs with
these nucleoside and nucleobase transporters. The information gained in
these studies is critical in the rational design, delivery and targeting
of clinically relevant nucleosides, nucleobases and their analogs to the
central nervous system.
核苷,核碱基及其类似物(例如Ganciclovir,Acyclovir,
二甲氧氨酸,偶氮苷)已迅速成为重要的治疗
治疗许多中枢神经系统病毒的药物
感染包括疱疹刺激性脑炎,巨细胞病毒
视网膜炎和与艾滋病相关的痴呆症复合物。发挥生物学作用
在中枢神经系统中,这些化合物必须穿透
血脑屏障(BBB)或血经脊髓液屏障(即
脉络丛),这是为保护环境提供保护环境的两个障碍
大脑。尽管BBB在
文学,脉络丛越来越明显
在调解许多重要的运输方面起着至关重要的作用
化合物进入中枢神经系统。值得注意的是,过去
在给予时期,我们证明了一个新颖的存在,广泛的
脉络丛中的选择性Na+ - 核苷共转运蛋白(N3)。在
此外,我们最近获得了令人兴奋的初步数据,表明
脉络膜中有一个新型的Na+依赖性转运蛋白用于核碱基
丛。在这种竞争更新中研究的总体目标
应用是了解核苷的机制,
核碱基及其结构类似物被转运在脉络膜中
丛。在拟议的研究中,我们计划:(1)确定结构
使用表达克隆策略在兔脉络丛中的N3; (2)
确定mRNA转录本的兔中的组织分布
编码N3; (3)确定位置(即基底外侧或刷子边框
脉络丛中N3的膜; (4)通过
嘌呤和嘧啶核苷在人脉络膜中转运
丛(5)确定核碱基的机制
在脉络丛中运输。确定结构的方法
N3的表达将克隆在Xenopus laevis卵母细胞中,
确定编码N3的cDNA的主要序列并推论其
氨基酸序列。确定N3的位置以及
脉络丛中的平衡性核苷转运蛋白,动力学
使用同位素摄取程序的研究将在培养中进行
在多孔过滤器和孤立的膜上生长的脉络丛单层
囊泡。 ATP耗尽组织切片中的同位素摄取研究将是
用于表征人类脉络丛中的核苷转运和
兔脉络膜中的核碱酶转运。特别是,我们会
阐明临床相关的核苷类似物与
这些核苷和核酶转运蛋白。获得的信息
这些研究对于理性设计,交付和定位至关重要
临床相关的核苷,核碱基及其类似物
中枢神经系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATHLEEN M GIACOMINI其他文献
KATHLEEN M GIACOMINI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATHLEEN M GIACOMINI', 18)}}的其他基金
Transporter Elucidation Center at the University of California, San Francisco
加州大学旧金山分校转运蛋白阐明中心
- 批准号:
10747230 - 财政年份:2023
- 资助金额:
$ 17.58万 - 项目类别:
Characterizing the physiological and pharmacological roles of SLC22A24
表征 SLC22A24 的生理和药理作用
- 批准号:
10371025 - 财政年份:2021
- 资助金额:
$ 17.58万 - 项目类别:
Characterizing the physiological and pharmacological roles of SLC22A24
表征 SLC22A24 的生理和药理作用
- 批准号:
10095957 - 财政年份:2021
- 资助金额:
$ 17.58万 - 项目类别:
Characterizing the physiological and pharmacological roles of SLC22A24
表征 SLC22A24 的生理和药理作用
- 批准号:
10595085 - 财政年份:2021
- 资助金额:
$ 17.58万 - 项目类别:
Drug-Vitamin Interactions Mediated by the Thiamine Transporter, SLC19A3
硫胺素转运蛋白 SLC19A3 介导的药物-维生素相互作用
- 批准号:
9918359 - 财政年份:2017
- 资助金额:
$ 17.58万 - 项目类别:
PGRN Administrative Coordination Hub, ACH (PGRN)
PGRN 行政协调中心,ACH (PGRN)
- 批准号:
9302796 - 财政年份:2015
- 资助金额:
$ 17.58万 - 项目类别:
PGRN Administrative Coordination Hub, ACH (PGRN)
PGRN 行政协调中心,ACH (PGRN)
- 批准号:
8946851 - 财政年份:2015
- 资助金额:
$ 17.58万 - 项目类别:
AUTOMATED DETECTION OF REGIONS OF INTEREST IN MEMBRANE TRANSPORTERS
自动检测膜转运蛋白感兴趣的区域
- 批准号:
8363594 - 财政年份:2011
- 资助金额:
$ 17.58万 - 项目类别:
相似国自然基金
RACK1通过调控Frizzled/G蛋白/PI3K通路参与小鼠基底膜平面细胞极性发育的机制研究
- 批准号:82301316
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ADSC在微流控系统中通过旁分泌上调HDF的COL4表达以促进皮肤基底膜再生的实验研究
- 批准号:82302838
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
抗肾小球基底膜病自身抗原层粘连蛋白-521致病性表位的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
短链脂肪酸丁酸在抗肾小球基底膜病中的免疫调节作用及机制研究
- 批准号:82270763
- 批准年份:2022
- 资助金额:50.00 万元
- 项目类别:面上项目
PXDN介导的基底膜中Col4A铰链在血管损伤后再内皮化及新生内膜病理发生中的作用及其机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
CELLULAR MECHANISMS OF DRUG TRANSPORT IN CHOROID PLEXUS
脉络丛药物转运的细胞机制
- 批准号:
2022305 - 财政年份:1991
- 资助金额:
$ 17.58万 - 项目类别:
CELLULAR MECHANISMS OF DRUG TRANSPORT IN CHOROID PLEXUS
脉络丛药物转运的细胞机制
- 批准号:
6490027 - 财政年份:1991
- 资助金额:
$ 17.58万 - 项目类别:
CELLULAR MECHANISMS OF DRUG TRANSPORT IN CHOROID PLEXUS
脉络丛药物转运的细胞机制
- 批准号:
2634674 - 财政年份:1991
- 资助金额:
$ 17.58万 - 项目类别:
CELLULAR MECHANISMS OF DRUG TRANSPORT IN CHOROID PLEXUS
脉络丛药物转运的细胞机制
- 批准号:
6138416 - 财政年份:1991
- 资助金额:
$ 17.58万 - 项目类别:
CELLULAR MECHANISMS OF DRUG TRANSPORT IN CHOROID PLEXUS
脉络丛药物转运的细胞机制
- 批准号:
2756766 - 财政年份:1991
- 资助金额:
$ 17.58万 - 项目类别: